Smokers need to be alert to this cancer.
In February of this year, the promotional department of the Yuchi Hospital, affiliated with the Zhejiang University School of Medicine, disclosed to the media that Zongqing, the founder of Nahaha, was in a stable state of affairs in the ICU ward. But less than three days later, Zongqing declared his death. According to media reports, 79-year-old Zongqing had been admitted to the hospital before the spring because of lung cancer and had been in poor condition and had been transferred to ICU for rescue.
His lung cancer is known to be closely linked to his years of smoking experience. According to media reports, Zongqing was once a smoker, on average two packs a day, over 30 years old. However, several years earlier he had decided to quit because of his health problems. After he quit smoking, his mental state and appearance improved significantly.
Lung cancer is generally classified into two main categories: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Small cell lung cancer (SCLC) is usually a low-level cancer, highly associated with smoking.
The post-Zongqing cancer is small cell lung cancer.
Lung cancer, one of the highest rates of morbidity and mortality in the world, is the number one cancer killer in my country, with the highest rate of morbidity and mortality. Small cell lung cancer is a highly malignant and fast-growing lung cancer type, accounting for about 20 per cent of lung cancer. It usually originates from a thin bronchial tube, but it is very early likely to spread to other parts, such as the brain, bones, liver and adrenal gland. Small-cell lung cancer is highly correlated with smoking, but may also be associated with other factors such as radon and asbestos exposure.
Symptoms of small-cell lung cancer include tremors of cough, cots, swelling of the face and neck, agitation, asthma, repeated pneumonia or bronchitis, muted sound, fatigue and loss of body weight for unknown reasons. As small cell lung cancer is easily diffused, it can also lead to a variety of symptoms, such as headaches, visual changes, weakness, epilepsy, back pains, assock pains, chest pains, shoulder pains or rib pains, abdominal pains, abdominal swelling and balms, as well as weakness of upper limb muscles, changes in vision and difficulties in swallowing.
Small cell lung cancer is divided into small cell lung cancer of limited duration and extensive small cell lung cancer. Small-cell lung cancer of the Bureau of limited duration occurs in only one lung and may spread to a nearby (on the collarbone) lymphocytal knots or compartments, but not to other parts. A wide range of small cell lung cancer has spread to another part, such as another lung leaf or brain. Treatment for small-cell lung cancer varies depending on the stage of cancer and other factors. The operation is rarely used for small cell lung cancer, but is sometimes considered if the chest X-ray or CT scans are accompanied by the discovery of a nodes. Supplementary chemotherapy (post-operative chemotherapy) is usually recommended if small cell lung cancer is subject to surgery. Cholera is usually required for small cell lung cancer and for extended periods of small cell lung cancer. Due to the sensitivity of small-cell lung cancer to chemotherapy and leaching, good results may be achieved after initial treatment, but re-emergence and drug resistance may occur soon. Integrated treatment is therefore key to achieving root causes.
For the treatment of small-cell lung cancer, in addition to surgery, chemotherapy and treatment, there are other treatments, such as immunotherapy and target-oriented treatment. The choice of these treatments depends on the patient ‘ s circumstances and the characteristics of the tumor.
Immunisation treatment: Immunisation treatment is a treatment that attacks cancer cells by activating the patient ‘ s own immune system. For small-cell lung cancer, immunotherapy drugs such as PD-1 inhibitor and PD-L1 inhibitor have shown some efficacy. These drugs can be used in conjunction with chemotherapy to improve treatment effectiveness.
Target therapy: Target therapy is a drug treatment method that addresses the specific molecular characteristics of cancer cells. Although there have been relatively few studies on the targeting of small-cell lung cancer, some studies have shown that the targeting of specific gene mutations can be effective for some small-cell lung cancer patients.
Absorption treatment: For small cell lung cancer that cannot be surgically removed, digestive treatment (e.g. radio-frequency digestion, microwave digestion, etc.) may be an effective local treatment. These methods are used to disrupt tumour tissues through high or low temperatures, thus achieving therapeutic purposes.
Supportive treatment: Supportive treatment (e.g. pain relief, nutritional support, psychological support, etc.) can improve the quality of life and survival of patients with advanced small cell lung cancer. In addition, for patients with symptoms, such as brain transfer, bone transfer, etc., corresponding treatment can be provided to alleviate the symptoms.
In general, the treatment of small-cell lung cancer requires the development of individualized treatments that take into account, inter alia, the patient ‘ s condition, tumours and physical condition. In the course of treatment, the patient should maintain a good mental attitude and actively cooperate with the doctor ‘ s advice in order to obtain the best treatment.
Small cell lung cancer.
